Pear Therapeutics, Inc. (PEAR) Social Stream
PEAR THERAPEUTICS INC (PEAR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PEAR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-29 | 3 | $13 | $13 | $13 | $0.118 | 10916.95% |
| 2022-01-03 | 4 | $13 | $12 | $12.5 | $0.118 | 10493.22% |
| 2022-03-29 | 5 | $13 | $5.5 | $10.166 | $0.118 | 8515.25% |
| 2022-05-16 | 5 | $16 | $5.5 | $11.375 | $0.118 | 9539.83% |
| 2022-05-17 | 5 | $13 | $5 | $10.5 | $0.118 | 8798.31% |
| 2022-06-06 | 5 | $13 | $5 | $10.25 | $0.118 | 8586.44% |
| 2022-06-16 | 6 | $12 | $5 | $9 | $0.118 | 7527.12% |
| 2022-08-12 | 6 | $13 | $2 | $9 | $0.118 | 7527.12% |
| 2022-08-15 | 6 | $11 | $2 | $7 | $0.118 | 5832.2% |
| 2022-10-20 | 6 | $11 | $2 | $6.4 | $0.118 | 5323.73% |
| 2022-11-08 | 6 | $11 | $2.3 | $6.46 | $0.118 | 5374.58% |
| 2022-11-16 | 6 | $11 | $2.8 | $6.36 | $0.118 | 5289.83% |
| 2022-12-09 | 6 | $8 | $2.8 | $5.16 | $0.118 | 4272.88% |
| 2023-03-17 | 6 | $5 | $2 | $4.25 | $0.118 | 3501.69% |
| NA | 1 | $NA | $NA | $NA | $0.118 | NA% |
The Trend in the Analyst Price Target
PEAR's average price target has moved down $8 over the prior 15 months.
PEAR reports an average of 347.22% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-17 | 5 | 13 | 5 | 10.250 | 4.27 | 140.05% |
| 2022-06-06 | 6 | 12 | 5 | 9.333 | 3.40 | 174.5% |
| 2022-08-12 | 6 | 13 | 2 | 9.000 | 2.00 | 350% |
| 2023-01-12 | 6 | 8 | 2 | 5.000 | 1.23 | 306.5% |
| 2023-03-17 | 5 | 5 | 2 | 4.250 | 0.39 | 989.74% |
PEAR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 0 | 3 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 26 weeks, PEAR's average broker recommendation rating worsened by 0.34.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PEAR has a greater upside potential (average analyst target price relative to current price) than 2194.21% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, PEAR THERAPEUTICS INC's average analyst price target is greater than 201.64% of them.
- PEAR has a higher number of analysts covering the stock than 421.31% of Technology stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, PEAR THERAPEUTICS INC's variance in analysts' estimates is lower than -1375.81% of them.
In the Healthcare industry, SSY, AIH, and BXRX are the three stocks most similar to PEAR THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for PEAR? Use POWR Ratings for clearer insight into price direction.